Johnson & Johnson (NYSE:JNJ) Upgraded by The Goldman Sachs Group to “Buy” Rating
The Goldman Sachs Group upgraded shares of Johnson & Johnson (NYSE:JNJ – Free Report) from a neutral rating to a buy rating in a research report sent to investors on Wednesday, MarketBeat.com reports. The brokerage currently has $172.00 price target on the stock, up from their prior price target of $157.00. A number of other […]
